Vorsitz/Chair: Verena Veulemans (Frankfurt am Main), Marc Michael Vorpahl (Siegburg)
Agenda
(P1533)
Sex-specific differences in biomarker expression in patients undergoing transcatheter edge-to-edge mitral valve repair and implications for outcome
M. Gröger (Ulm)
Zum Abstract
(P1534)
Exercise stress echocardiography reveals pulmonary congestion in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair
C. Meindl (Regensburg)
Zum Abstract
(P1535)
Die Mitralklappen-Transkatheter-Edge-to-Edge-Reparatur (MV-TEER) bei Patienten mit sekundärer Mitralklappeninsuffizienz optimiert Hämodynamik, Nierenfunktion und Lebensqualität
B. Markus (Marburg)
Zum Abstract
(P1536)
Protamingabe zur Prävention von Blutungskomplikationen nach Mitral-TEER
O. Bisht (Coburg)
Zum Abstract
(P1537)
Exercise midregional pro-atrial natriuretic peptide (MR-proANP) as a potential diagnostic tool to identify dynamic mitral regurgitation
S. Knebelkamp (Bad Nauheim)
Zum Abstract
(P1538)
Calcific aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk
P. R. Goody (Bonn)
Zum Abstract
(P1539)
MRproANP – a promising biomarker for left-atrial and left-ventricular remodeling